  |
3C9N |
Crystal Structure of a SARS Corona Virus Derived Peptide Bound to the Human Major Histocompatibility Complex Class I molecule HLA-B*1501 |
C |
A |
MHC antigen-recognition domain |
 |
  |
3BZF |
The human non-classical major histocompatibility complex molecule HLA-E |
P |
A |
MHC antigen-recognition domain |
|
  |
3BWA |
Crystal Structure of HLA B*3508 in complex with a HCMV 8-mer peptide from the pp65 protein |
C |
A |
MHC antigen-recognition domain |
|
  |
3BW9 |
Crystal Structure of HLA B*3508 in complex with a HCMV 12-mer peptide from the pp65 protein |
C |
A |
MHC antigen-recognition domain |
|
  |
2VLL |
THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN |
C |
A |
MHC antigen-recognition domain |
|
  |
2VAA |
MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN |
P |
A |
MHC antigen-recognition domain |
|
  |
2VAB |
MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN |
P |
A |
MHC antigen-recognition domain |
|
  |
2V2X |
T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT. |
C |
A |
MHC antigen-recognition domain |
|
  |
2V2W |
T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT |
C |
A |
MHC antigen-recognition domain |
|
  |
2SEB |
X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II |
E |
ABD |
MHC antigen-recognition domain |
|
  |
2RFX |
Crystal Structure of HLA-B*5701, presenting the self peptide, LSSPVTKSF |
C |
A |
MHC antigen-recognition domain |
|
  |
2PYE |
Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC RevealNative Diagonal Binding Geometry TCR Clone C5C1 Complexed with MHC |
C |
DEA |
MHC antigen-recognition domain |
|
  |
2PXY |
Crystal structures of immune receptor complexes |
P |
BACD |
MHC antigen-recognition domain |
|
  |
2P5W |
Crystal structures of high affinity human T-cell receptors bound to pMHC reveal native diagonal binding geometry |
C |
DEA |
MHC antigen-recognition domain |
|
  |
2P5E |
Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC Reveal Native Diagonal Binding Geometry |
C |
DEA |
MHC antigen-recognition domain |
|
  |
2NW3 |
Crystal structure of HLA-B*3508 presenting EBV peptide EPLPQGQLTAY at 1.7A |
C |
A |
MHC antigen-recognition domain |
|
  |
2NNA |
Structure of the MHC class II molecule HLA-DQ8 bound with a deamidated gluten peptide |
C |
AB |
MHC antigen-recognition domain |
|
  |
2MHA |
CRYSTAL STRUCTURE OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I H-2KB MOLECULE CONTAINING A SINGLE VIRAL PEPTIDE: IMPLICATIONS FOR PEPTIDE BINDING AND T-CELL RECEPTOR RECOGNITION |
E |
A |
MHC antigen-recognition domain |
|
  |
2HN7 |
HLA-A*1101 in complex with HBV peptide homologue |
C |
A |
MHC antigen-recognition domain |
|
  |
2HJL |
Crystal Structure of HLA-B5703 and HIV-1 peptide |
C |
A |
MHC antigen-recognition domain |
|
  |
2HJK |
Crystal Structure of HLA-B5703 and HIV-1 peptide |
C |
A |
MHC antigen-recognition domain |
|
  |
2H6P |
Crystal structure of HLA-B*3501 presenting the human cytochrome P450 derived peptide, KPIVVLHGY |
C |
A |
MHC antigen-recognition domain |
|
  |
2GUO |
Human Class I MHC HLA-A2 in complex with the native nonameric Melan-A/MART-1(27-35) peptide |
C |
A |
MHC antigen-recognition domain |
|
  |
2GTW |
Human Class I MHC HLA-A2 in complex with the nonameric Melan-A/MART-1(27-35) peptide having A27L substitution |
C |
A |
MHC antigen-recognition domain |
|
  |
2GTZ |
Human Class I MHC HLA-A2 in complex with the nonameric Melan-A/MART-1(27-35) peptide having A28L substitution |
C |
A |
MHC antigen-recognition domain |
|
  |
2GT9 |
Human Class I MHC HLA-A2 in complex with the decameric Melan-A/MART-1(26-35) peptide |
C |
A |
MHC antigen-recognition domain |
|
  |
2GIT |
Human Class I MHC HLA-A2 in complex with the modified HTLV-1 TAX (Y5K-4-[3-Indolyl]-butyric acid) peptide |
C |
A |
MHC antigen-recognition domain |
|
  |
2G9H |
Crystal Structure of Staphylococcal Enterotoxin I (SEI) in Complex with a Human MHC class II Molecule |
C |
ABD |
MHC antigen-recognition domain |
|
  |
2FZ3 |
The role of T cell receptor alpha genes in directing human MHC restriction |
C |
A |
MHC antigen-recognition domain |
|
  |
2DYP |
Crystal Structure of LILRB2(LIR2/ILT4/CD85d) complexed with HLA-G |
C |
A |
MHC antigen-recognition domain |
|
  |
2CLR |
THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE |
C |
A |
MHC antigen-recognition domain |
|
  |
2CLV |
MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM8 PEPTIDE |
C |
A |
MHC antigen-recognition domain |
|
  |
2CLZ |
MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM1 PEPTIDE |
C |
A |
MHC antigen-recognition domain |
|
  |
2CIK |
INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM CYTOCHROME P450. |
C |
A |
MHC antigen-recognition domain |
|
  |
2C7U |
CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. |
C |
A |
MHC antigen-recognition domain |
|
  |
2BVQ |
STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION |
C |
A |
MHC antigen-recognition domain |
|
  |
2BVP |
STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION |
C |
A |
MHC antigen-recognition domain |
|
  |
2BVO |
STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION |
C |
A |
MHC antigen-recognition domain |
|
  |
2BSR |
CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 |
C |
A |
MHC antigen-recognition domain |
|
  |
2BSS |
CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 |
C |
A |
MHC antigen-recognition domain |
|
  |
2BST |
CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 |
C |
A |
MHC antigen-recognition domain |
|
  |
2AXG |
The Immunogenicity of a Viral Cytotoxic T Cell Epitope is controlled by its MHC-bound Conformation |
C |
A |
MHC antigen-recognition domain |
|
  |
2AXF |
The Immunogenicity of a Viral Cytotoxic T Cell Epitope is controlled by its MHC-bound Conformation |
C |
A |
MHC antigen-recognition domain |
|
  |
2AV7 |
Crystal structure of HTLV-1 TAX peptide Bound to Human Class I MHC HLA-A2 with the K66A mutation in the heavy chain. |
C |
A |
MHC antigen-recognition domain |
|
  |
2AV1 |
Crystal structure of HTLV-1 TAX peptide Bound to Human Class I MHC HLA-A2 with the E63Q and K66A mutations in the heavy chain. |
C |
A |
MHC antigen-recognition domain |
|
  |
2A83 |
Crystal structure of hla-b*2705 complexed with the glucagon receptor (gr) peptide (residues 412-420) |
C |
A |
MHC antigen-recognition domain |
|
  |
1ZT1 |
crystal structure of class I MHC H-2Kk in complex with an octapeptide |
P |
A |
MHC antigen-recognition domain |
|
  |
1ZSD |
Crystal Structure Of HLA-B*3501 Presenting an 11-Mer EBV Antigen EPLPQGQLTAY |
C |
A |
MHC antigen-recognition domain |
|
  |
1ZHL |
Crystal structure of HLA-B*3508 presenting 13-mer EBV antigen LPEPLPQGQLTAY |
C |
A |
MHC antigen-recognition domain |
|
  |
1ZHK |
Crystal structure of HLA-B*3501 presenting 13-mer EBV antigen LPEPLPQGQLTAY |
C |
A |
MHC antigen-recognition domain |
|
